This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today announced it has granted Immunome, Inc. (Nasdaq: IMNM) ...

Boster Biological Technology advances biotechnology research with its cutting-edge multiplex ELISA service, delivering ...

Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab: New York Friday, January 24, 2025, 17:00 Hrs [IST] ...

Scientists have discovered a new type of anti-malarial antibody that doesn't interfere with current vaccines, at least in mouse models. Could they help eliminate malaria in the future?

The discovery comes at a time when malaria ... of Allergy and Infectious Diseases in Maryland, US. Anti-malarial monoclonal antibodies (mAbs) are another promising new tool that have been shown ...

Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Following on from its news yesterday of the discovery of new immune biomarkers in patients with non-active secondary progressive multiple sclerosis (na-SPMS) treated with nasal foralumab, the Company ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences), a leading innovation-driven biopharmaceutical company dedicated to the discovery ... Reimbursement Drug List (NRDL) (2024 Edition).